Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
13 Février 2018 - 10:44PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO
FILE
REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 001-36435
ENZON
PHARMACEUTICALS, INC.
(Exact name of registrant as specified in
its charter)
20 Commerce Drive (Suite 135)
Cranford, New Jersey 07016
(732) 980-4500
(Address,
including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Series A Junior Participating Preferred
Stock Purchase Rights
(Title of each class of securities covered
by this Form)
Common Stock, $0.01 par value
(Titles
of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
|
ý
|
Rule 12g-4(a)(2)
|
¨
|
Rule 12h-3(b)(1)(i)
|
ý
|
Rule 12h-3(b)(1)(ii)
|
¨
|
Rule 15d-6
|
¨
|
Rule 15d-22(b)
|
¨
|
(1)
|
The Series A Junior Participating Preferred Stock Purchase Rights (the “Rights”) expired on April 30, 2017, pursuant to the terms of the Section 382 Rights Agreement, dated as of May 1, 2014, by and between Enzon Pharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, as rights agent. Enzon Pharmaceuticals, Inc. previously filed a Registration Statement on Form 8-A to register the Rights on May 1, 2014.
|
Approximate
number of holders of record as of the certification or notice date:
None
Pursuant to the requirements
of the Securities Exchange Act of 1934, Enzon Pharmaceuticals, Inc. has caused this certification/notice to be signed on its behalf
by the undersigned duly authorized person.
|
ENZON PHARMACEUTICALS, INC.
|
|
|
|
|
Date: February 13, 2018
|
By:
|
/s/ Andrew Rackear
|
|
Name:
|
Andrew Rackear
|
|
Title:
|
Chief Executive Officer and Secretary
|
Enzon (QX) (USOTC:ENZN)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Enzon (QX) (USOTC:ENZN)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024